Category: New products
-
Electric Crispr Chip Quickly Detects Covid-19 Virus
An engineering lab developed a chip device that uses gene editing and an electric field to detect viruses responsible for Covid-19 infections.
-
Online App Encourages Abstinence in Alcohol Addiction
Results from a clinical trial show users of an online abstinence training app are less likely to relapse in alcohol consumption than sham training app users.
-
Crispr Therapy Shown to Help Blood Disorder Patients
Interim clinical trial results show an experimental treatment derived from gene-edited stem cells relieves symptoms in patients with severe inherited blood diseases.
-
Flexible Device Attaches to Heart, Monitors Functions
Biomedical engineers designed a thin flexible implantable patch that attaches to the heart, monitors its functions, and can perform therapeutics.
-
Trial Shows Covid-19 Vaccine Safety, Immune Response
First results from an early-stage clinical trial show an RNA-based vaccine to prevent Covid-19 infections is safe and produces a complex immune response.
-
Inhaled Dry-Powder Covid-19 Antibodies in the Works
Two biotechnology companies are developing synthetic antibodies to treat Covid-19 infections formulated as an inhaled dry powder rather than an infusion.
-
Wearable Data Help Detect Covid-19 Cases
Data from smart watches and fitness trackers, when combined with symptom reports, can show that the wearers likely have Covid-19 infections.
-
Covid-19 Antibodies Cut Viral Load, Medical Visits
Interim results from a clinical trial show a synthetic antibody drug reduces viral burden and medical visits among non-hospitalized Covid-19 patients.
-
200M Covid-19 Vaccine Doses Donated to Int’l Effort
Sanofi and GlaxoSmithKline are offering 200 million doses of their Covid-19 vaccine for a project devoted to making vaccines equitably available worldwide.
-
Better Precision Medicine Outcomes Shown for Leukemia
Clinical trial results show a strategy that first tests for genomic mutations to guide treatments results in better outcomes for patients with acute myeloid leukemia.